KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Cash & Equivalents: 2009-2025

Historic Cash & Equivalents for Lam Research (LRCX) over the last 17 years, with FY2025 value amounting to $6.4 billion.

  • Lam Research's Cash & Equivalents rose 1031.03% to $6.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 billion, marking a year-over-year increase of 1031.03%. This contributed to the annual value of $6.4 billion for FY2025, which is 928.21% up from last year.
  • According to the latest figures from FY2025, Lam Research's Cash & Equivalents is $6.4 billion, which was up 928.21% from $5.8 billion recorded in FY2024.
  • Lam Research's 5-year Cash & Equivalents high stood at $6.4 billion for FY2025, and its period low was $3.5 billion during FY2022.
  • In the last 5 years, Lam Research's Cash & Equivalents had a median value of $5.3 billion in 2023 and averaged $5.1 billion.
  • As far as peak fluctuations go, Lam Research's Cash & Equivalents tumbled by 2028.54% in 2022, and later skyrocketed by 5153.48% in 2023.
  • Over the past 5 years, Lam Research's Cash & Equivalents (Annual) stood at $4.4 billion in 2021, then dropped by 20.29% to $3.5 billion in 2022, then soared by 51.53% to $5.3 billion in 2023, then increased by 9.57% to $5.8 billion in 2024, then grew by 9.28% to $6.4 billion in 2025.
  • Its last three reported values are $6.4 billion in FY2025, $5.8 billion for FY2024, and $5.3 billion during FY2023.